nodes	percent_of_prediction	percent_of_DWPC	metapath
Acepromazine—HTR2A—conduct disorder	0.9	1	CbGaD
Acepromazine—DRD1—Dopamine receptors—DRD4—conduct disorder	0.00882	0.0969	CbGpPWpGaD
Acepromazine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.00666	0.0732	CbGpPWpGaD
Acepromazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.00389	0.0428	CbGpPWpGaD
Acepromazine—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.00386	0.0425	CbGpPWpGaD
Acepromazine—HTR1A—Serotonin receptors—HTR2A—conduct disorder	0.00246	0.027	CbGpPWpGaD
Acepromazine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.00211	0.0232	CbGpPWpGaD
Acepromazine—SLC22A1—Norepinephrine Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00202	0.0222	CbGpPWpGaD
Acepromazine—DRD1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.002	0.022	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—DRD4—conduct disorder	0.00195	0.0214	CbGpPWpGaD
Acepromazine—HTR1A—Monoamine GPCRs—DRD4—conduct disorder	0.00168	0.0184	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—DRD4—conduct disorder	0.00164	0.018	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—DRD4—conduct disorder	0.0016	0.0175	CbGpPWpGaD
Acepromazine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00151	0.0166	CbGpPWpGaD
Acepromazine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.00147	0.0162	CbGpPWpGaD
Acepromazine—HTR2A—Monoamine GPCRs—DRD4—conduct disorder	0.00145	0.0159	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—DRD4—conduct disorder	0.00142	0.0156	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00141	0.0155	CbGpPWpGaD
Acepromazine—ADRA1B—Amine ligand-binding receptors—DRD4—conduct disorder	0.00134	0.0147	CbGpPWpGaD
Acepromazine—DRD1—Monoamine GPCRs—HTR2A—conduct disorder	0.00127	0.014	CbGpPWpGaD
Acepromazine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.00124	0.0136	CbGpPWpGaD
Acepromazine—HTR2A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00122	0.0134	CbGpPWpGaD
Acepromazine—DRD1—G alpha (s) signalling events—CGA—conduct disorder	0.00121	0.0133	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—DRD4—conduct disorder	0.00119	0.0131	CbGpPWpGaD
Acepromazine—HTR1A—Monoamine GPCRs—HTR2A—conduct disorder	0.00109	0.012	CbGpPWpGaD
Acepromazine—DRD1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00107	0.0117	CbGpPWpGaD
Acepromazine—ADRA1B—Monoamine GPCRs—HTR2A—conduct disorder	0.00104	0.0114	CbGpPWpGaD
Acepromazine—SLC22A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.00103	0.0113	CbGpPWpGaD
Acepromazine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.00096	0.0106	CbGpPWpGaD
Acepromazine—ADRA1A—Monoamine GPCRs—HTR2A—conduct disorder	0.000925	0.0102	CbGpPWpGaD
Acepromazine—HTR1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000919	0.0101	CbGpPWpGaD
Acepromazine—ADRA1B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000875	0.00962	CbGpPWpGaD
Acepromazine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000807	0.00887	CbGpPWpGaD
Acepromazine—ADRA1A—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000777	0.00854	CbGpPWpGaD
Acepromazine—Propiomazine—DRD4—conduct disorder	0.000685	0.0725	CrCbGaD
Acepromazine—HTR2A—GPCRs, Other—DRD4—conduct disorder	0.000643	0.00707	CbGpPWpGaD
Acepromazine—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000616	0.00677	CbGpPWpGaD
Acepromazine—Cyamemazine—HTR2A—conduct disorder	0.000615	0.0651	CrCbGaD
Acepromazine—Methotrimeprazine—DRD4—conduct disorder	0.000585	0.062	CrCbGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000575	0.00632	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000514	0.00565	CbGpPWpGaD
Acepromazine—Promazine—DRD4—conduct disorder	0.000507	0.0538	CrCbGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000495	0.00544	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—SLC6A4—conduct disorder	0.000488	0.00537	CbGpPWpGaD
Acepromazine—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.000472	0.00518	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000471	0.00518	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—DRD4—conduct disorder	0.000459	0.00505	CbGpPWpGaD
Acepromazine—Chlorpromazine—DRD4—conduct disorder	0.000446	0.0473	CrCbGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000444	0.00488	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—CGA—conduct disorder	0.000438	0.00482	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000434	0.00477	CbGpPWpGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000427	0.0047	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000419	0.0046	CbGpPWpGaD
Acepromazine—Clomipramine—SLC6A4—conduct disorder	0.000391	0.0414	CrCbGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000387	0.00425	CbGpPWpGaD
Acepromazine—Thioproperazine—HTR2A—conduct disorder	0.000386	0.0409	CrCbGaD
Acepromazine—Thiothixene—HTR2A—conduct disorder	0.00038	0.0402	CrCbGaD
Acepromazine—Pipotiazine—HTR2A—conduct disorder	0.00038	0.0402	CrCbGaD
Acepromazine—HTR1A—GPCR ligand binding—CGA—conduct disorder	0.000377	0.00414	CbGpPWpGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000376	0.00413	CbGpPWpGaD
Acepromazine—Mesoridazine—HTR2A—conduct disorder	0.000375	0.0397	CrCbGaD
Acepromazine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.000369	0.00405	CbGpPWpGaD
Acepromazine—Trimipramine—SLC6A4—conduct disorder	0.000359	0.0381	CrCbGaD
Acepromazine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.000359	0.00394	CbGpPWpGaD
Acepromazine—HTR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.000348	0.00383	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.000347	0.00381	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000334	0.00368	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.000331	0.00364	CbGpPWpGaD
Acepromazine—Fluphenazine—HTR2A—conduct disorder	0.000328	0.0348	CrCbGaD
Acepromazine—HTR2A—GPCR ligand binding—CGA—conduct disorder	0.000325	0.00358	CbGpPWpGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000323	0.00355	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000322	0.00354	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.000319	0.0035	CbGpPWpGaD
Acepromazine—Propiomazine—HTR2A—conduct disorder	0.000316	0.0335	CrCbGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000316	0.00347	CbGpPWpGaD
Acepromazine—Desipramine—SLC6A4—conduct disorder	0.000314	0.0333	CrCbGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000308	0.00338	CbGpPWpGaD
Acepromazine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.000306	0.00336	CbGpPWpGaD
Acepromazine—Clomipramine—HTR2A—conduct disorder	0.0003	0.0318	CrCbGaD
Acepromazine—Chlorprothixene—HTR2A—conduct disorder	0.000299	0.0317	CrCbGaD
Acepromazine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000296	0.00326	CbGpPWpGaD
Acepromazine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000294	0.00323	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000284	0.00312	CbGpPWpGaD
Acepromazine—Thioridazine—HTR2A—conduct disorder	0.000283	0.03	CrCbGaD
Acepromazine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000279	0.00307	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000277	0.00305	CbGpPWpGaD
Acepromazine—Trimipramine—HTR2A—conduct disorder	0.000276	0.0293	CrCbGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000274	0.00301	CbGpPWpGaD
Acepromazine—Methotrimeprazine—HTR2A—conduct disorder	0.00027	0.0286	CrCbGaD
Acepromazine—Imipramine—SLC6A4—conduct disorder	0.000267	0.0282	CrCbGaD
Acepromazine—Promethazine—HTR2A—conduct disorder	0.000266	0.0282	CrCbGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000264	0.0029	CbGpPWpGaD
Acepromazine—Trifluoperazine—HTR2A—conduct disorder	0.000262	0.0278	CrCbGaD
Acepromazine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00026	0.00286	CbGpPWpGaD
Acepromazine—Perphenazine—HTR2A—conduct disorder	0.00026	0.0275	CrCbGaD
Acepromazine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000254	0.00279	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000248	0.00272	CbGpPWpGaD
Acepromazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000245	0.0027	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000245	0.0027	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000243	0.00267	CbGpPWpGaD
Acepromazine—Desipramine—HTR2A—conduct disorder	0.000242	0.0256	CrCbGaD
Acepromazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000239	0.00263	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000234	0.00258	CbGpPWpGaD
Acepromazine—Promazine—HTR2A—conduct disorder	0.000234	0.0248	CrCbGaD
Acepromazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000232	0.00256	CbGpPWpGaD
Acepromazine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000231	0.00254	CbGpPWpGaD
Acepromazine—SLC22A1—Neuronal System—COMT—conduct disorder	0.000227	0.0025	CbGpPWpGaD
Acepromazine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.000225	0.00248	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000225	0.00247	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000213	0.00234	CbGpPWpGaD
Acepromazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000211	0.00232	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000211	0.00232	CbGpPWpGaD
Acepromazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00021	0.00231	CbGpPWpGaD
Acepromazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000207	0.00227	CbGpPWpGaD
Acepromazine—Chlorpromazine—HTR2A—conduct disorder	0.000206	0.0218	CrCbGaD
Acepromazine—Imipramine—HTR2A—conduct disorder	0.000205	0.0217	CrCbGaD
Acepromazine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000203	0.00223	CbGpPWpGaD
Acepromazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000201	0.00221	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000201	0.00221	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000193	0.00212	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00019	0.00209	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000187	0.00205	CbGpPWpGaD
Acepromazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000185	0.00204	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.000185	0.00204	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000184	0.00202	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000184	0.00202	CbGpPWpGaD
Acepromazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000182	0.002	CbGpPWpGaD
Acepromazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000181	0.00199	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.00018	0.00198	CbGpPWpGaD
Acepromazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000178	0.00196	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000178	0.00196	CbGpPWpGaD
Acepromazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000172	0.00189	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00017	0.00187	CbGpPWpGaD
Acepromazine—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00017	0.00186	CbGpPWpGaD
Acepromazine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000167	0.00184	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000167	0.00184	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000164	0.0018	CbGpPWpGaD
Acepromazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00016	0.00176	CbGpPWpGaD
Acepromazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000159	0.00174	CbGpPWpGaD
Acepromazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000159	0.00174	CbGpPWpGaD
Acepromazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000153	0.00168	CbGpPWpGaD
Acepromazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000144	0.00159	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000139	0.00152	CbGpPWpGaD
Acepromazine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000138	0.00151	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—CGA—conduct disorder	0.000133	0.00146	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000131	0.00144	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—CGA—conduct disorder	0.000127	0.00139	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.000126	0.00138	CbGpPWpGaD
Acepromazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.000121	0.00133	CbGpPWpGaD
Acepromazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.00012	0.00132	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	0.000119	0.00131	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000116	0.00128	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—CGA—conduct disorder	0.000114	0.00126	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.000114	0.00125	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000109	0.0012	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	0.000108	0.00119	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—WASF1—conduct disorder	0.000106	0.00117	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.000105	0.00115	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000103	0.00113	CbGpPWpGaD
Acepromazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	0.000103	0.00113	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000101	0.00111	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—CGA—conduct disorder	0.0001	0.0011	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—CGA—conduct disorder	9.87e-05	0.00108	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	9.66e-05	0.00106	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	9.51e-05	0.00104	CbGpPWpGaD
Acepromazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	9.35e-05	0.00103	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	9.16e-05	0.00101	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—WASF1—conduct disorder	9.15e-05	0.00101	CbGpPWpGaD
Acepromazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	9.05e-05	0.000994	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	8.72e-05	0.000958	CbGpPWpGaD
Acepromazine—ALB—Metabolism—CGA—conduct disorder	8.47e-05	0.000931	CbGpPWpGaD
Acepromazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	8.22e-05	0.000903	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—WASF1—conduct disorder	8.04e-05	0.000883	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	7.91e-05	0.000869	CbGpPWpGaD
Acepromazine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	7.78e-05	0.000855	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	7.74e-05	0.000851	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—DRD4—conduct disorder	7.44e-05	0.000817	CbGpPWpGaD
Acepromazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	7.41e-05	0.000814	CbGpPWpGaD
Acepromazine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	7.06e-05	0.000776	CbGpPWpGaD
Acepromazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	6.83e-05	0.000751	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	6.73e-05	0.000739	CbGpPWpGaD
Acepromazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	6.58e-05	0.000723	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—DRD4—conduct disorder	6.4e-05	0.000703	CbGpPWpGaD
Acepromazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	6.2e-05	0.000682	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	6.09e-05	0.000669	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	5.98e-05	0.000657	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—COMT—conduct disorder	5.72e-05	0.000628	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—MAOA—conduct disorder	5.68e-05	0.000624	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—DRD4—conduct disorder	5.62e-05	0.000617	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	5.53e-05	0.000607	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	5.41e-05	0.000595	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	4.85e-05	0.000533	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	4.17e-05	0.000459	CbGpPWpGaD
Acepromazine—ALB—Hemostasis—EP300—conduct disorder	4.05e-05	0.000445	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	3.97e-05	0.000437	CbGpPWpGaD
Acepromazine—ALB—Metabolism—COMT—conduct disorder	3.82e-05	0.00042	CbGpPWpGaD
Acepromazine—ALB—Metabolism—MAOA—conduct disorder	3.8e-05	0.000417	CbGpPWpGaD
Acepromazine—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.68e-05	0.000405	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	3.66e-05	0.000403	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	3.53e-05	0.000388	CbGpPWpGaD
Acepromazine—DRD1—Signaling Pathways—EP300—conduct disorder	2.57e-05	0.000283	CbGpPWpGaD
Acepromazine—SLC22A1—Metabolism—EP300—conduct disorder	2.45e-05	0.000269	CbGpPWpGaD
Acepromazine—HTR1A—Signaling Pathways—EP300—conduct disorder	2.21e-05	0.000243	CbGpPWpGaD
Acepromazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	2.11e-05	0.000231	CbGpPWpGaD
Acepromazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.94e-05	0.000213	CbGpPWpGaD
Acepromazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.91e-05	0.00021	CbGpPWpGaD
Acepromazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.87e-05	0.000206	CbGpPWpGaD
Acepromazine—ALB—Metabolism—EP300—conduct disorder	1.64e-05	0.00018	CbGpPWpGaD
